Peripheral blood lymphocytes' DNA damage in different treatment outcomes of chronic viral C hepatitis genotype 4 infection

Journal of Medical Sciences (Faisalabad)

Volumn 13, Issue 5, 2013, Pages 353-359

  Mahmoud, Mohammed ^a   El Tokhy, Safinaz ^a   El Lebedy, Dalia ^a   Elfotouh, Mohammed Abu ^b   El Arabi, Ghada H ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b El Tawfik Military Clinics   (Egypt)

^c MINISTRY OF HEALTH   (Egypt)

Author keywords

DNA damage; Hepatitis C virus; Interferon therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DNA; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS REACTIVATION;

EID: 84878990353     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2013.353.359     Document Type: Article

References (27)

1. Azqueta, A., Y. Lorenzo and A.R. Collins, 2009. In vitro comet assay for DNA repair: A warning concerning application to cultured cells. Mutagenesis, 24: 379-381.
2. Bhargava, A., G. Raghuram, N. Pathak, S. Varshney, S. Jatawa, D. Jain and P.K. Mishra, 2011. Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic. Biol. Med., 51: 1806-1814.
3. Blasiak, J., E. Gloc, K. Wozniak, J. Drzewoski, M. Zadrozny and T. Pertynski, 2003. Free radicals scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat. Res., 535: 25-34.
4. Bolukbas, C., F. Bolukbas, A. Kocyigit, M. Aslan, S. Selek, M. Bitiren and M. Ulukanligil, 2006. Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various clinical forms of hepatitis B. J. Gastroenterol. Hepatol., 21: 610-616.
5. Castillo, I., E. Rodriguez-Inigo, J.M. Lopez-Alcorocho, M. Pardo, J. Bartolome and V. Carreno, 2006. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin. Infect. Dis., 15: 1277-1283.
6. Chayama, K., S. Takahashi, J. Toyota, Y. Karino and K. Ikeda et al., 2012. Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Hepatology, 55: 742-748.
7. Collins, A.R., 2004. The comet assay for DNA damage and repair: Principles, applications and limitations. Mol. Biotechnol., 26: 249-261.
8. DeWolfe Millera, F. and L.J. Abu-Raddad, 2010. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc. Natl. Acad. Sci. USA., 107: 14757-14762.
9. Deng, L., T. Adachi, K. Kitayama, Y. Bungyoku and S. Kitazawa et al., 2008. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J. Virol., 82: 10375-10385.
10. Dustin, L.B. and C.M. Rice, 2007. Flying under the radar: The immunobiology of hepatitis C. Annu. Rev. Immunol., 25: 71-99.
11. El-Ray, A., R. Moucari, M. El-Ghannam, A.A. Taha and M.A. Saber et al., 2010. Insulin resistance: A major predictor of significant liver fibrosis in egyptian patients with genotype 4 chronic hepatitis C. J. Hepatol., 52: S409-S409.
12. Esmat, G. and S. Abdel Fattah, 2009. Evaluation of a novel pegylated interferon alpha-2a (Reiferon Retard ®) in Egyptian patients with chronic hepatitis C genotype 4. Digest. Liver Disease, 3: 17-19.
13. Grossi, S., A. Sumberaz, M. Gozma, F. Matiolli, G. Testino and A. Martelli, 2008. DNA damage in peripheral blood lymphocytes of patients with cirrhosis related to alcohol abuse or to hepatitis B and C viruses. Eur. J. Gastroenterol. Hepatol., 20: 22-25.
14. Kassie, F., W. Parzefall and S. Knasmuller, 2000. Single cell gel electrophoresis assay: A new technique for human biomonitoring studies. Mutat. Res., 463: 13-31.
15. La Vignera, S., R.A. Condorelli, E. Vicari, R. D'Agata, A.E. Calogero, 2012. Sperm DNA damage in patients with chronic viral C hepatitis. Eur. J. Intern. Med., 23: e19-E24.
16. Loft, S. and H.E. Poulsen, 1999. Markers of oxidative damage to DNA: Antioxidants and molecular damage. Meth. Enzymol., 300: 166-184.
17. Machida, K., H. Tsukamoto, J. Liu, Y. Han and S. Govindarajan et al., 2010. c-Jun mediates HCV hepatocarcinogenesis through STAT3 andnitric oxide-dependent impairment of oxidative DNA repair. Hepatology, 52: 480-492.
18. McKenna, D.J., S.R. McKeown and V.J. McKelvey-Martin, 2008. Potential use of the comet assay in the clinical management of cancer. Mutagenesis, 23: 183-190.
19. Moller, P., 2006. The alkaline comet assay: Towards validation in biomonitory of DNA damaging exposures. Basic Clin. Pharmacol. Toxicol., 98: 336-345.
20. Murata, M., R. Thanan, N. Ma and S. Kawanishi, 2012. Role of Nitrative and Oxidative DNA damage ininflammation-related carcinogenesis. J. Biomed. Biotechnol., 10.1155/2012/623019
21. Pal, S., S.J. Polyak, N. Bano, W.C. Qiu and R.L. Carithers et al., 2010. Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. J. Gastroenterol. Hepatol., 25: 627-634.
22. Radkowski, M., J.F. Gallegos-Orozco, J. Jablonska, T.V. Colby and B Walewska-Zielecka et al. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology, 41: 106-114.
23. Sanefuji, K., H. Kayashima, T. Iguchi, K. Sugimachi and Y. Yamashita et al., 2009. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. J. Surg. Oncol., 99: 32-37.
24. Sherman, K.E., R. Fleischer, K. Laessig, J. Murray, W. Tauber and D. Birnkrant, 2007. Development of novel agents for the treatment of chronic hepatitis C infection: summary of the FDA Antiviral Products Advisory Committee recommendations. Hepatology, 46: 2014-2020.
25. Singh, N.P., M.T. McCoy, R.R. Tice and E.L. Schneider, 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175: 184-191.
26. Trzeciak, A.R., J. Barnes and M.K. Evans, 2008. A modified alkaline comet assay for measuring DNA repair capacity in human populations. Radiat Res., 169: 110-121.
27. Welker, M.W. and S. Zeuzem, 2009. Occult hepatitis C: how convincing are the current data? Hepatology, 49: 665-675.